Thanks very much for your insight. Management is in Australia next week selling the deal. (Expect more broker notes) and CSLA have increased price target on the stock from $6.69 to $6.95...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025